Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) is offered by National Institutes of Health. Max award: $6,444,000. Applications close on Oct 13, 2028.
| Opportunity number | RFA-HL-27-010 |
|---|---|
| Agency | National Institutes of Health |
| Status | Posted |
| Posted | Oct 9, 2026 |
| Closes | Oct 13, 2028 |
| Award ceiling | $6,444,000 |
| Award floor | $2,180,000 |
| Total program funding | $10,804,000 |
| Expected awards | 10 |
| Who can apply | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Category | Health |
Summary (excerpt)
The purpose of the Stimulating Access to Research in Residency Transition Scholar (StARRTS) K38 Career Development program is to retain and support clinician-investigators who have successfully completed the Stimulating Access to Research in Residency (StARR) R38 Program ( RFA-HL-26-012 and previous NOFOs) as resident-investigators. Individuals who receive K38 grants described in this Notice of Funding Opportunity (NOFO) will be referred to as Tr…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from National Institutes of Health